Patient-specific comorbidities as prognostic variables for survival in myelofibrosis

Treatment decisions in primary myelofibrosis (PMF) are guided by numerous prognostic systems. Patient-specific comorbidities have influence on treatment-related survival and are considered in clinical contexts but have not been routinely incorporated into current prognostic models. We hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sochacki, Andrew L., Bejan, Cosmin Adrian, Zhao, Shilin, Patel, Ameet, Kishtagari, Ashwin, Spaulding, Travis P., Silver, Alexander J., Stockton, Shannon S., Pugh, Kelly, Dorand, R. Dixon, Bhatta, Manasa, Strayer, Nicholas, Zhang, Siwei, Snider, Christina A., Stricker, Thomas, Nazha, Aziz, Bick, Alexander G., Xu, Yaomin, Savona, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989522/
https://www.ncbi.nlm.nih.gov/pubmed/35420683
http://dx.doi.org/10.1182/bloodadvances.2021006318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989522/
https://www.ncbi.nlm.nih.gov/pubmed/35420683
http://dx.doi.org/10.1182/bloodadvances.2021006318

Ejemplares similares